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To define epitopes of tetanus toxin, we compared four different in vitro systems in terms of their ability to
produce tetanus toxin-specific subfragments from cloned DNA. A transcription-translation system developed
from a nontoxigenic strain of Clostridium tetani was found to yield predominantly full-sized peptides. Such
peptides were used to map six different epitopes for eight monoclonal antibodies. The toxin-neutralizing
properties of the antibodies were determined in an in vitro assay, based on the toxin-mediated inhibition of
norepinephrine release from rat brain particles. Two monoclonal antibodies recognizing epitopes within the
regions Ser-744 to Ser-864 and Ile-1224 to Asp-1315 could neutralize the toxin. A third nonneutralizing
antibody was shown to recognize the synthetic peptide Phe-947 to Glu-967 derived from the tetanus toxin
sequence. This peptide contains a human T-cell epitope.
Tetanus toxin is a highly potent neurotoxin produced by
the anaerobic bacterium Clostridium tetani. The toxin
blocks release of inhibitory transmitter substances from
central synapses (21) after a process that involves binding to
ganglioside receptors at the nerve termini, receptor-medi-
ated endocytosis, intra-axonal transport, and transsynaptic
transfer (13, 25).
The structural gene for the toxin is located on a 75-
kilobase (kb) plasmid (8, 11, 16) and has been sequenced
recently (8, 9). The toxin (Mr 150,700) is synthesized as a
single-chain polypeptide. Upon release from the bacterium,
it is processed by endogenous proteases into two subunits,
designated A and BC, which are held together by a single
disulfide bond (4, 8). Proteolytic cleavage is paralleled by an
increase in toxicity (3, 35), and the A-fragment is translo-
cated into the cytoplasm to block transmitter release (2).
Efficient resistance to tetanus is induced by vaccination
with formaldehyde-treated toxin or toxin subfragments (10,
15, 34). In this study we searched for an in vitro system that
allows the characterization of toxin-neutralizing antibodies.
For this purpose, we first compared different cell-free sys-
tems for their capacity to produce nontoxic peptides from
cloned toxin-specific DNA. We show that a transcription-
translation system established from a nontoxigenic strain of
C. tetani was superior to other systems in furnishing full-
sized peptides. Second, we mapped epitopes for monoclonal
antibodies originally raised against tetanus toxin or toxoid
with recombinant polypeptides. Third, two antibodies, bind-
ing to different epitopes within the C-terminal part of the
BC-fragment, blocked the toxin-specific effects on the re-
lease of norepinephrine from rat brain homogenates in vitro.
A third antibody which did not show the toxin-neutralizing
effect was inhibited by a synthetic peptide carrying a human
T-cell epitope.
MATERIALS AND METHODS
Bacteria and plasmids. C. tetani EK11, a nontoxigenic
variant of E88 (strain Massachusetts), was kindly provided
by Dr. Engelhardt (Behringwerke, Marburg, Federal Repub-
* Corresponding author.
lic of Germany [FRG]). Escherichia coli JM101 (23) and
HB101 (6) were used for purification of pUC12 and pUC13,
pSP64 and pSP65 (22), or pGEM1 and pGEM2 plasmid
vectors (Promega Biotech, Madison, Wis.). The pEx3la,
pEx3lb, and pEx31c vectors (32) carrying a polylinker in
three reading frames within the MS2 polymerase gene were
kindly provided by E. Beck (Zentrum fur Molekularbiologie,
Heidelberg, FRG).
Enzymes and chemicals. Restriction endonucleases, T4
DNA ligase, Klenow polymerase, SP6 and T7 RNA poly-
merases, RNasin, and nucleotides were purchased from
Boehringer. L-[355]methionine (>800 Ci/mmol), [3H]norepi-
nephrine (43.7 Ci/mmol), and Amplify were from Amersham
Buchler (Braunschweig, FRG); diethylpyrocarbonate was
from Sigma Chemical Co. (Deisenhofen, FRG); and protein
A-Sepharose was from Pharmacia (Freiburg, FRG).
Cloning of DNA. Cloning of defined tetanus toxin-specific
DNA fragments (Table 1) was performed under L2B1 con-
tainment following standard protocols (18). For nucleotide
numbers defining the positions within the tetanus toxin gene,
see Eisel et al. (8). The vectors pEJ5 and pEJ97, described
previously (8), contain the toxin promoter region within 548
and 322 5' noncoding nucleotides, respectively, placed up-
stream from the tetS and tet97 sequences listed in Table 1.
In vitro synthesis of capped mRNA. The details of in vitro
transcription have been described previously (19). The char-
acteristics of the transcripts and of the corresponding pep-
tides are summarized in Table 1.
In vitro translation of toxin-specific mRNA. Nuclease-
treated wheat germ extract was purchased from Bethesda
Research Laboratories (Neu-Isenburg, FRG) and optimized
with tetS-specific RNA at 25°C. Optimal results were ob-
tained with 1.0 p.g of RNA in a 15-pdl assay mix. Nuclease-
treated rabbit reticulocyte lysate was obtained from Amer-
sham. Translation reactions were performed according to
the manufacturer's protocol. A 15-,lI assay mix contained
1.0 ,ug of RNA and 10 ,uCi of [35S]methionine.
Expression in a cell-free system from E. coli. A DNA-
directed nuclease-treated S30 extract from E. coli was pur-
chased from Amersham and optimized by the method of
Pratt (27) with pAT153 DNA as a control. A 15-pI assay mix
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 at university library on Septem







TETANUS TOXIN SUBFRAGMENT EXPRESSION AND EPITOPES
TABLE 1. Plasmid vectors for the synthesis of tetanus toxin-specific polypeptides
Tetanus toxin-specific Length of Size of
Designation Parental vector' sequencesb transcriptc (nt) polypeptide (Da)
pSP64tet5 pSP64 (HincII-BamHI) -2 to 1215 (SnaBI-BglII) 1,259 46,935
pSP64tet97 pSP64 (HincII-EcoRI) -2 to 1604 (SnaBI-EcoRI) 1,630 61,806
pGEMtet6 pGEM1 (HindlIl-HincII) 1215 to 2227 (BglII-BgIII)e 1,076 38,382
pGEMtet266 pGEM2 (EcoRI-HindIII) 2002 to 2774 (HpaII-HpaIIf 820 28,843
pGEMtet9 pGEM1 (HincII-EcoRI) 2401 to 2774 (XbaI-EcoRI)9 1,292 47,392
pEJ4 pEJ97 (SnaBI-EcoRI) 3155 to 3673 (ScaI-EcoRI) 19,657
pEJ5 pUC12 (BamHI) -548 to 1215 (BglII) 46,935
pEJ97 pUC12 (HindIII-EcoRI) -322 to 1604 (HindlIl-EcoRI) 61,806
pEJ6 pUC12 (BamHI) 1215 to 2227 (BglII-BglII) 38,382
pExtet5l pEx3lb (31) (BamHI)g -2 to 273 (SnaBI-NcoI)9 23,021
pExtet52 pEx3lb (BamHI-BglII)9 270 to 1218 (NcoI-Bg1II)9 47,225
pExtet53 pEx3lb (BamHI)g -2 to 735 (SnaBI-BsmI)h 40,021
pExtet3l pEx3la (Bg(II-BamHI)9 2228 to 3155 (BglII-ScaI) 49,163
pExtet7 pEx3la (EcoRI) 1603 to 3673 (EcoRI-EcoRI) 93,366
pExtetlS pEx3lc (EcoRI-HindII) 1810 to 3945 (HincIl-HindIll)Y 92,482
a Sites used for subcloning shown in brackets.
b Numbered according to Eisel et al. (8).
Termination of transcription was obtained by cleavage downstream from the coding sequences. nt, Nucleotides.
d Deduced from the nucleotide sequence.
The fragment was cloned into the BamHI site of pUC12 and recovered by digestion with HindIll and SmaI.
f Ends were filled in with Klenow polymerase, and the fragment was subcloned into the Scal site of M13E1 (26) and released with EcoRI and HindIll.
9 Ends were filled in with Klenow polymerase.
h Protruding ends were removed with E. coli DNA polymerase.
'The fragment was cloned into pHK400 (8) and released with EcoRI and HindIII.
contained 15 ,uCi of L-[35S]methionine and 2 ,ug of plasmid
DNA.
Development of a cell-free protein-synthesizing system from
C. tetani EK1l. An S30 extract was prepared from C. tetani
according to Pratt (27) with the following modifications.
EK11 cells were grown to an optical density at 490 nm of 1.6.
The cells were lysed under anaerobic conditions by a single
passage through a French press. A low-molecular-weight
mixture (LM-mix; 375 ,ul) was freshly prepared from stock
solutions as follows: 40 p.1 of 2.2 M Tris-acetate, pH 8.2; 5 p.1
of 0.55 M dithiothreitol; 50 p.1 of 38 mM ATP, pH 7.0; 15 p.1
of a mix containing 88 mM each CTP, GTP, and UTP, pH
7.0; 100 ,u1 of 0.42 M phosphoenolpyruvate, pH 7.0; 10 p.l of
amino acid mix (each amino acid at 55 mM, excluding
methionine); 75 p.l of 40% (wt/vol) polyethylene glycol 6000;
20 p.1 of folinic acid (2.7 mg/ml); 20 p.1 of E. coli tRNA (17.4
mg/ml); and 40 p.1 of salt solution (1.4 M ammonium acetate,
1.4 M potassium acetate, 0.38 M calcium acetate). The
concentration of S30 extract was varied in a range between
10 and 60 p.g of protein per assay mix, yielding optimal
protein synthesis with 1 p. (20 p.g of protein) of S30 extract.
The time dependence of incorporation of radiolabeled me-
thionine was followed for 15 to 75 min. Protein synthesis
proceeded rapidly for 35 min and reached its highest levels
after 45 min. The Mg2" and K+ concentrations were varied
in the range of 5 to 25 mM and 0 to 120 mM, respectively.
Optimal protein synthesis was obtained with 14 mM Mg2+
and 80 mM K+. A 15-,ul assay mix contained 1 p.1 of S30
extract, 3.75 p.1 of LM-mix, 13 mM magnesium acetate, 7.5
p.Ci of L-[35S]methionine, and 2 to 5 p.g of cesium chloride
gradient-purified plasmid DNA. The mixture was preincu-
bated without methionine and DNA for 20 min in 2.2-ml
Eppendorf cups (wide bottom) in a rotating (270 rpm) water
bath at 37°C. The reaction was started by the addition of
[35S]methionine and DNA. After a 40-min pulse, 40 p.g of
unlabeled methionine was added, and incubation was con-
tinued for 5 min.
Alternatively, the reactions were carried out in the pres-
ence of 10.0 ,uCi of [35S]methionine diluted with unlabeled
methionine to a final concentration of 5 p.M. The samples
were centrifuged for 4 min in an Eppendorf centrifuge and
analyzed as described below.
Characterization of the expression products. Samples of the
assay mixes were analyzed under reducing conditions by
sodium dodecyl sulfate (SDS)-polyacrylamide gel electro-
phoresis (PAGE) on 13% polyacrylamide gels. Immunopre-
cipitations with protein A-Sepharose were performed in
RIPA buffer as described previously (26). For Western
immunoblotting analyses, the method of Blake et al. (5) was
used. Enzyme linked immunosorbent assay (ELISA) reac-
tions were performed with the immunoglobulin G (IgG)-
horseradish peroxidase method (33).
Immunization of rabbits with toxin-specific fusion proteins.
Fusion proteins containing an N-terminal part of the MS2
polymerase fused in frame to the Tet5, Tet7, or Teti5
regions of the toxin were induced and purified as described
before (8, 32). The enriched protein fraction (4.0 mg of
protein per ml) was mixed with complete Freund adjuvant
prior to immunization of 6-week-old New Zealand White
rabbits. Each rabbit received about 100 p.g of antigen,
injected intradermally. Antibody titers were determined by
ELISA with purified tetanus toxin as well as the correspond-
ing fusion protein as antigens. For optimal titers, rabbits
were boosted 3 weeks after the first injection with the same
amount of antigen lacking adjuvant. Ten days later, serum
was collected.
Inhibition of [3H]norepinephrine release from rat brain
homogenate. The experimental procedure has been pub-
lished in detail previously (12). Briefly, prewashed rat brain
homogenate was suspended at 2% (wt/vol) in Krebs-Ringer-
HEPES buffer (KRH; 130 mM NaCl, 4.75 mM KCI, 2.54
mM CaC12, 1.2 mM KH2PO4, 1.2 mM MgSO4, 10 mM
HEPES [N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic
acid], 11 mM glucose, 20 p.M ascorbic acid, 10 p.M isonico-
tinic acid 2-isopropylhydrazide) and incubated for 15 min at
37°C with the same volume of KRH containing 2 p.Ci of
[3H]norepinephrine per ml. After two washing steps with the
same buffer lacking the radiolabeled compound, 200 p.l of the
VOL. 57, 1989 3499
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FIG. 1. Restriction map of the tetanus toxin gene. The open box
corresponds to the coding region. Restriction sites used for cloning
into expression vectors are indicated. Positions corresponding to the
proteolytic cleavage sites between the A- and BC-fragments (solid
arrow) and fragment-C (open arrow) are marked. Restriction sites
used to map epitopes following in vitro transcription-translation or
expression of individual gene fragments in E. coli are indicated: B,
BglII; Bs, BsmI; E, EcoRI; H, HpaII; Hi, HincII; HIII, HindIII; K,
KpnI; N, NcoI; S, ScaI; Sn, SnaBI; X, XbaI. Solid bars indicate the
locations of domains recognized by individual monoclonal antibod-
ies as mapped in this study: I, 993D5 and 993D5B4; II, 161D6 and
162D2; III, 161A1; IV, 104A1; V, 164B4 and 165B2. Regions IVa, V,
and VIa indicate positions of human T-cell-specific epitopes as
mapped previously (7).
preloaded suspension (2% wt/vol) was mixed with 100 ,ul of
a solution of tetanus toxin (200 ng/ml in KRH containing
0.1% bovine serum albumin) which had been preincubated
for 30 min at room temperature with the individual antiserum
or preimmune serum. After 2 h at 37°C, the samples were
transferred to Millipore GF-C glass fiber filters and washed
with KRH buffer for 15 min. For a 2-min pulse, the potas-
sium ion concentration was increased to 31 mM, while the
sodium ion concentration was simultaneously reduced to 106
mM. This treatment generally released about 40% of the
total radiolabel from control samples. The capacity of indi-
vidual antisera to abolish the inhibitory effects of tetanus
toxin on release was determined by measuring the levels of
extracellular and total radiolabeled norepinephrine. Each
antiserum was tested in three independent experiments,
yielding essentially identical results. Toxin neutralization
studies involving monoclonal antibodies were initially per-
formed with unpurified ascites fluids. When toxin neutrali-
zation was observed, tests were repeated with purified IgG
at concentrations corresponding to the dilutions in Table 2.
RESULTS
In vitro synthesis of tetanus toxin-specific fragments from in
vitro-synthesized mRNA. Our first approach to obtain defined
toxin-specific peptides was based on the in vitro synthesis of
mRNA and its subsequent translation in appropriate trans-
lation systems. Five different constructs containing different
fragments of the toxin gene (Fig. 1) were prepared in pSP64
or pGEM vectors as explained in Table 1.
By using SP6 RNA polymerase and DNA templates that
were linearized downstream from the toxin-specific se-
quences, mRNA of the expected size was obtained in
microgram yields (data not shown). For subsequent transla-
tion assays in reticulocyte lysate, the mRNA was capped by
adding the capping analog m7G5'ppp5'G in a 10-fold excess
over GTP. In the wheat germ system, capping did not
improve the translation efficiency, as also documented by
others (29).
M C 97 5 6 266 9
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FIG. 2. In vitro translation of toxin-specific mRNA in wheat
germ extract (A) or reticulocyte lysate (B). RNA encoding individ-
ual portions of tetanus toxin as indicated by the numbers above the
lanes was obtained by in vitro transcription. The translation prod-
ucts were labeled with [35S]methionine and analyzed on 13% poly-
acrylamide gels. Lane C, Control translation without exogenous
RNA. M, Molecular masses of unlabeled marker proteins (in kilo-
daltons).
Figure 2 compares the results obtained by translating the
individual mRNA species in wheat germ extract (A) and
reticulocyte lysate (B). The peptides Tet97 and Tet5 had the
authentic N terminus of the toxin molecule; Tet97, however,
contained the entire TetS sequence and 131 additional C-
terminal amino acids. Although in both translation systems
peptides of the size corresponding to the coding capacity
(Table 1) were obtained, smaller peptides of identical size
were formed from tet97 and tetS mRNAs, indicating that
these smaller products could arise from premature termina-
tion of translation. The formation of the second-largest
product obtained from pGEMtet9 could result from ribo-
somal slippage and initiation at a second AUG codon 61
nucleotides downstream from initiation codon 2427. In gen-
eral, the reticulocyte lysate system yielded larger amounts of
peptides than were obtained in the wheat germ system. It
should be noted, however, that both eucaryotic systems
were less efficient in translating internal or C-terminal se-
quences of the toxin molecule.
Cell-free protein synthesis in E. coli or C. tetani lysates. The
constructs pEJ5 and pEJ97 contained 5' noncoding se-
quences harboring the toxin promoter shown to be func-
tional in E. coli (8). Figure 3 shows that polypeptides of the
expected size, 64 and 47 kilodaltons (kDa), were obtained.
The replacement of the toxin promoter by strong E. coli
promoters (such as lac or tac), as well as the replacement of
the clostridial Shine-Dalgarno sequence by a synthetic se-
quence corresponding to the ompA gene, did not improve
yields. In addition, neither modification of ionic conditions
nor alteration of the spermidine or ATP concentration led to
full-sized products (data not shown). In some instances, as
shown for pEJ6 (Fig. 3, lane 6), the majority of radiolabel
was apparently incorporated into P-lactamase (indicated by
the arrowheads). The recombinant plasmid should yield a
toxin-specific 41,583-Da protein corresponding to the largest
molecular species barely detected in lane 6. For comparison,
see the peptides synthesized from pAT153 control DNA,
also carrying the ampicillin resistance gene, in lane +c.
Linearization of the plasmids rather diminished the yields of
peptides.
For these reasons, we developed a cell-free protein-
synthesizing system from a nontoxigenic strain of C. tetani.
Under optimized conditions, a 30-fold stimulation of protein
INFECT. IMMUN.
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FIG. 3. Cell-free protein synthesis in the E. coli system.
[35S]methionine-labeled products were analyzed by SDS-PAGE as
before. Supercoiled DNA, obtained by centrifugation on cesium
chloride gradients, was used from various recombinants. Lane -C,
No added DNA; lane +C, pAT153; lanes 97, 5, and 6, products
obtained from pEJ97, pEJ5, and pEJ6, respectively. M, Molecular
mass markers (in kilodaltons).
synthesis was obtained with 10 pug of exogenous total RNA
from C. tetani (Fig. 4A). It should be noted that a plateau
value was not reached even at the highest RNA concentra-
tion tested (666 pug/ml). Stimulation by exogenous DNA was
less efficient than stimulation by RNA. In combined tran-
scription-translation assays, the best results were obtained
with 2 to 5 ,ug of supercoiled DNA, yielding a 3.5-fold
stimulation of protein synthesis.
The clostridial system was superior to the previous sys-
tems since it yielded predominantly full-sized peptides,
irrespective of whether the toxin-specific sequences were
derived from the N- or C-terminal part of the molecule (Fig.
4B). With none of the other systems could the 23,100-Da
peptide, representing Tet4 (Fig. 1), be obtained in adequate
amounts. This peptide was expressed at high levels under
control of the toxin promoter (Fig. 4B, lane d). The clostrid-
ial system, however, was not very efficient when expression
was driven by the lac promoter. From pEJ6, for example,
the largest detectable peptide (32,000 Da) was considerably
smaller than the expected 41,580-Da species. In vitro studies
involving RNA polymerase purified from C. tetani indicated
that this polymerase transcribed genes under control of the
lac or tac promoter, albeit at a reduced efficiency (U. Eisel
and H. Niemann, unpublished).
Mapping of antigenic determinants. In a first attempt to
apply peptides synthesized in the clostridial system in the
characterization of 22 different monoclonal antibodies raised
against tetanus toxin or toxoid (1), we performed immuno-
precipitation reactions (Table 2). Figure 4C shows an exam-
ple of such an experiment. Antibody 993D5 precipitated the
Tet97 and Tet5 peptides equally well (lanes a and c), while
antibody 161D6 or 162D2 recognized Tet97 exclusively,
indicating that the corresponding epitope was located within
the additional C-terminal sequences present in Tet97. Since
these latter two antibodies were specific for the BC-fragment
(Table 2), their epitopes had to reside within region II in Fig.
1.
To our surprise, however, only eight monoclonal antibod-
ies (Table 2) could be applied successfully in immunoprecip-
itations of in vitro-translated peptides. The amounts of
recombinant peptides obtained by in vitro translations were
not sufficient to be analyzed by ELISA or Westem blotting.
Therefore, we extended our studies to fusion proteins syn-
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FIG. 4. Cell-free protein synthesis in a system from C. tetani.
(A) Stimulation by exogenous RNA. Total RNA was isolated from
C. tetani E88 by phenol-guanidinium hydrochloride and added to a
15-,ul translation assay mix containing 1 ,ul of S30 extract, 14 mM
Mg2 , 80 mM K+, and 10 ,uCi of [355]methionine. After incubation
for 45 min at 37°C, radiolabel incorporation was determined by
trichloroacetic acid precipitation in two independent sets of exper-
iments. (B) Combined transcription-translation. Supercoiled DNA
(2 ,ug) of various recombinants was transcribed and translated in the
cell-free system as detailed in Materials and Methods. [35S]methio-
nine-labeled samples were analyzed by SDS-PAGE and autoradiog-
raphy. Lane a, Peptides obtained from pEJ97; lane b, peptides from
pEJ5; lane c, peptides from pEJ6; lane d, peptides from pEJ4; lane
e, no DNA added. M, Molecular mass markers (in kilodaltons). (C)
Immunoprecipitation of individual peptides with monoclonal anti-
bodies. Lanes a and b, Peptides obtained from pEJ97 precipitated
with monoclonal antibody 161D6 or 993D5, respectively; lane c,
peptides obtained from pEJ5 immunoprecipitated with L-chain-
specific monoclonal antibody 993D5; lane d, the same as in lane c
except that antibody 161D6 was used; lane e, immunoprecipitation
of the products obtained from pEJ4 with the anti-Tetl5 polyclonal
rabbit serum.
bound to fusion proteins containing Tet5 and Tet97 se-
quences as well as those containing Tet53. In contrast,
fusion proteins consisting of Tet52 or Tet5l were not recog-
nized, although such fusion proteins were equally well
precipitated with a polyclonal serum. These findings suggest
that both antibodies recognized an epitope (region I in Fig. 1)
located in the vicinity of amino acid 90, the border between
the Tet5l and Tet52 sequences. Computer-assisted analyses
of the toxin sequence by the method of Hopp and Woods
(14) indicated a strong epitope, D(81)SDKDR(86), in this
domain. This predicted epitope had the highest Ah value
(2.55) of the entire toxin molecule.
The data obtained with the MS2-Tet fusion proteins con-
firmed the results obtained by immunoprecipitation of in
vitro-translated peptides (Table 2). No additional epitopes
could be detected with this experimental approach, how-
ever.
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FIG. 5. Mapping of the epitope for monoclonal antibody 993D5
with MS2-toxin fusion proteins. Specific regions of the toxin gene as
indicated were cloned in frame into pEx3l vectors and transfected
into E. coli ts537 cells. Cultures were grown overnight at 32°C
(nonpermissive temperature). Synthesis of the fusion proteins was
induced by diluting the cultures fivefold in medium preheated to
42°C (permissive temperature). Incubation was continued for 4 h.
Cells were lysed and extracted as described by Strebel et al. (32),
separated by SDS-PAGE, and analyzed by Western blotting with
monoclonal antibody 993D5. Note that the products from tet5l were
analyzed on a 15% gel together with the molecular mass markers (M)
on the right-hand side. The arrow indicates a band not present in
control cells or cells expressing other fusion proteins. The corre-
sponding material was immunoprecipitable with polyclonal rabbit
sera against Tet5 (not shown). T, Tetanus toxin; C, gels were stained
with Coomassie brilliant blue; B, after blotting onto nitrocellulose
sheets and incubation with the monoclonal antibody at 60 ,ug of
protein per ml. Bound antibody was visualized with peroxidase-
conjugated goat anti-mouse IgG as previously described (5).
homogenate. The toxin-neutralizing properties of the mono-
clonal antibodies listed in Table 2 were tested together with
those of polyclonal sera raised against fusion proteins in an
in vitro assay based on the inhibitory effects of tetanus toxin
on the release of [3H]norepinephrine from brain homogenate
prelabeled with the hormone (12). The results are summa-
rized in Table 2 and Fig. 6. Two of the monoclonal sera,
104A1 and 75A4, were capable of completely blocking the
toxin effect. Similar results were obtained with polyclonal







FIG. 6. Toxin-neutralizing properties of polyclonal and mono-
clonal antibodies. Rat brain homogenate was preloaded with[3H]norepinephrine and treated for 2 h with tetanus toxin (67 ng/ml,
final concentration) or toxin that was preincubated with individual
antisera at the dilutions indicated. After a 2-min pulse with 31 mM
K+, the levels of extracellular and cellular norepinephrine were
determined by scintillation counting. The results are expressed as
the mean of triplicate determinations in independent experiments.
Fur further details, see Materials and Methods. (A) No tetanus toxin
added. (B) Tetanus toxin without antisera. (C through I) Tetanus
toxin was preincubated with one of the following antisera: C,
anti-Tet5; D, anti-Tetl5; E, anti-Tet7; F, monoclonal 104A1; G,
monoclonal 164B4; H, monoclonal 75A4; I, negative control ascites.
For IgG concentrations of monoclonal antibodies, see Table 2.
contrast, antibodies that recognized domains within the
A-fragment, such as 993D5 and anti-tet5, were less efficient
in neutralizing the toxin in this in vitro assay.
DISCUSSION
We used recombinant tetanus toxin-specific peptides to
characterize the epitopes of monoclonal antibodies whose
toxin-neutralizing activity was determined in an in vitro
assay. Four different cell-free systems were compared for
their efficiency in producing subfragments of the toxin mol-
ecule in vitro from cloned DNA. This study was carried out
because previous experiments had indicated that clostridial
DNA with a G+C content of merely 27% was expressed at
low levels in E. coli (8). Our studies showed that clostridial
DNA yielded preferentially full-sized peptides in a homolo-
gous cell-free system developed from a nontoxigenic strain
of C. tetani. Optimization studies revealed a similar depen-
dency of this system on Mg2+ (13 to 15 mM) and K+ (80 mM)
as described for systems from E. coli (27), Bacillus subtilis
(17, 20, 36), and Clostridium pasteurianum (30, 31). Total
RNA from C. tetani stimulated protein synthesis in the
clostridial system about 30-fold at a concentration of 300
,ug/ml. Stallcup et al. (31) reported a sixfold stimulation with
similar amounts of RNA with a reconstituted S30 extract
from C. pasteurianum. Only a 3.5-fold stimulation, however,
was obtained with supercoiled exogenous DNA containing
the promoter of the toxin gene. Fractionation and reconsti-
tution of the S30 extract according to protocols published for
C. pasteurianum (31) did not improve the levels of transcrip-
tion in our system.
In reticulocyte lysate and wheat germ extract systems, the
translation efficiency of presynthesized toxin-specific mRNA
was quite low in comparison to that of standard globin or
coronaviral mRNA (19). In both systems, premature termi-
nation of translation was a major reason for the reduced
yields. The combined transcription-translation system forE.
coli did not prove satisfactory with clostridial DNA. Even
though ribosomes from gram-negative bacteria have been
reported to be less restricted with respect to the nature of the
mRNA than ribosomes from gram-positive organisms (31),
exogenously added total clostridial RNA was translated
quite inefficiently in the E. coli system (not shown). In
addition, peptides encoded by entirely toxin-specific DNA
were again poorly synthesized in vivo, while MS2 fusion
proteins were made in normal amounts, as shown in Fig. 5.
These findings suggest that in this system, initiation of
translation could play the crucial role.
Using such recombinant peptides, we coarsely mapped
the epitopes of eight monoclonal antibodies. Of a total of 22
different antisera, all of which were shown previously to
bind to tetanus toxin (1), only 8 reacted with toxin fragments
produced either in vitro or in vivo, as determined by
immunoprecipitation, ELISA, or Western blotting. These
eight monoclonal antibodies recognized six different epitopes.
None of the eight antibodies alone was capable of neutral-
izing 10 50% lethal doses when coinjected into mice; each
only prolonged the time to death. Similar observations have
been reported previously (24, 34). However, such in vivo
experiments are costly in terms of test animals and mono-
clonal antisera. Therefore, to assess the toxin-neutralizing
activity of monoclonal antibodies, we used an in vitro
system in which the essential steps of the toxification pro-
cess, namely, binding and internalization of the toxin, are
maintained. Our data demonstrate that sera directed against
the A-subunit of tetanus toxin, such as polyclonal rabbit
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anti-Tet5 or the monoclonal antibody 993D5, which could be
used in immunoprecipitations and thus presumably also bind
to the toxin in solution, barely neutralized the toxin. Similar
properties of monoclonal antibodies against the A-fragment
have been reported previously (34). Three epitopes were
mapped with the help of monoclonal antibodies in the
B-fragment. This domain of the toxin has been suggested to
play an important role in the interaction of the toxin with a
putative proteinaceous receptor (25) and could be involved
in the translocation of the A-subunit into the cytosole
(reviewed in reference 13). One of the antibodies (104A1)
caused marked neutralization of the toxin by binding to
region IV, while antibodies 162D2 and 161D6, both recog-
nizing region II of the toxin and both useful in immunopre-
cipitations, only reduced the toxin effects to about 20% of
the value without antibody. Unfortunately, no conclusions
concerning binding of antibodies to epitopes III and V can be
drawn, since the corresponding antibodies (161A1 for region
III, 164B4 and 165B2 for region V) did not bind to radiola-
beled tetanus toxin in solution (data not shown). In compet-
itive ELISA reactions, binding of the latter two antibodies to
region V could be specifically inhibited by the synthetic
peptide NH2-F(947)NNFTVSFWLRVPKVSASHLE(967),
carrying a human T-cell epitope (7). Apparently region V
becomes exposed at the periphery of the molecule only after
treatment with detergent or, in the host, after proteolytic
processing by antigen-presenting cells. Our finding suggests
that B cells and T cells can principally recognize the same
epitope. We cannot exclude, however, that a peptide of 21
amino acids exhibits more than the one epitope and that the
murine B-cell and the human T-cell clones therefore recog-
nize two different sites. Recently, a pentapeptide sequence
from human cytomegalovirus was demonstrated to be suffi-
cient for major histocompatibility complex-restricted T-cell
stimulation (28). Systematic modifications of the peptide
from either end will now allow the precise characterization
of the T- and B-cell epitope(s). In agreement with published
observations (10, 15, 34), antibodies binding to fragment-C
showed the most pronounced toxin-neutralizing activities.
This is not surprising, since fragment-C has been shown to
be nearly as effective as the holotoxin with respect to binding
to thyroid or neural membranes or to certain gangliosides.
Recent studies have indicated that monoclonal antibody
75A4 indeed inhibits binding of tetanus toxin to gangliosides
(H. Niemann, unpublished observation). Epitope VI is lo-
calized within the 80 carboxy-terminal amino acids. Al-
though steric hindrance caused by the bound antibody
cannot be excluded as an indirect reason for inhibition of
toxin binding, it is possible that this part of the toxin
molecule participates directly in the binding to the ganglio-
side receptor.
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